Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, randomised controlled trial

Journal:

The Lancet

Published:

2025-09-01

DOI:

10.1016/s0140-6736(25)01585-5

Affiliations:

34

Authors:

29

Go to article

Institutions	Authors	Share
Uppsala University (UU), Sweden	5.666667	0.20
Sahlgrenska Academy, GU, Sweden	3.500000	0.13
Karolinska University Hospital, Sweden	2.000000	0.07
Karolinska Institute (KI), Sweden	1.500000	0.05
Sundsvall District Hospital, Sweden	1.000000	0.04
Skåne University Hospital (SUS), Sweden	1.000000	0.04
NU Hospital Group, Sweden	1.000000	0.04
Kristianstad Hospital, Sweden	1.000000	0.04
Lund University (LU), Sweden	1.000000	0.04
Skaraborg Hospital Skövde, Sweden	1.000000	0.04
Örebro University, Sweden	1.000000	0.04
Södra Älvsborg Hospital (SÄS), Sweden	1.000000	0.04
Länssjukhuset i Kalmar, Sweden	1.000000	0.04
Umeå University (UMU), Sweden	1.000000	0.04
Västerås Central Hospital, Sweden	0.500000	0.02
Västerviks sjukhus, Sweden	0.500000	0.02
Linköping University (LiU), Sweden	0.500000	0.02
Sunderby Central Hospital of Norrbotten, Sweden	0.500000	0.02
Region Värmland, Sweden	0.500000	0.02
Sahlgrenska University Hospital (SU), GU, Sweden	0.500000	0.02
Hallands Hospital Halmstad (HH), Sweden	0.500000	0.02
Länssjukhuset Ryhov Jönköping, Sweden	0.500000	0.02
Stockholm South General Hospital, Sweden	0.500000	0.02
Helsingborg Hospital, Sweden	0.500000	0.02
Gävle Hospital, Sweden	0.333333	0.01

Interested in Cardiovascular Medicine and Haematology?